HC Wainwright reissued their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Performance NYSEAMERICAN ARMP opened at $3.91 on Friday. The company has a market cap of $141.35 million, […]